Cardiac-resynchronization therapy significantly reduces mortality in advanced heart failure patients when combined with an implantable defibrillator.
Does cardiac-resynchronization therapy with or without an implantable defibrillator reduce the combined risk of death or hospitalization and mortality in patients with advanced heart failure and a prolonged QRS interval?
Patients with advanced chronic heart failure and a prolonged QRS interval
Cardiac-resynchronization therapy with or without an implantable defibrillator
Combined risk of death from any cause or first hospitalization, and mortalitycomposite
In patients with advanced heart failure and a prolonged QRS interval, cardiac-resynchronization therapy reduces death or hospitalization, and adding a defibrillator further reduces mortality.
In patients with advanced heart failure and a prolonged QRS interval, cardiac-resynchronization therapy decreases the combined risk of death from any cause or first hospitalization and, when combined with an implantable defibrillator, significantly reduces mortality.
Building similarity graph...
Analyzing shared references across papers
Loading...
Michael R. Bristow
Leslie A. Saxon
John Boehmer
New England Journal of Medicine
University of California, San Francisco
University of Wisconsin–Madison
University of Southern California
Building similarity graph...
Analyzing shared references across papers
Loading...
Bristow et al. (Wed,) reported a other. Cardiac-resynchronization therapy significantly reduces mortality in advanced heart failure patients when combined with an implantable defibrillator.
www.synapsesocial.com/papers/697817fb78c42d0bce33a074 — DOI: https://doi.org/10.1056/nejmoa032423